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Abstract
Positive affect is associated with a number of health benefits; however, few studies have examined the relationship
between positive affect and cerebral glucose metabolism, a key energy source for neuronal function and a possible index of
brain health. We sought to determine if positive affect was associated with cerebral glucose metabolism in late middle-aged
adults (n¼133). Participants completed the positive affect subscale of the Center for Epidemiological Studies Depression
Scale at two time points over a two-year period and underwent 18F-fluorodeoxyglucose-positron emission tomography
scanning. After controlling for age, sex, perceived health status, depressive symptoms, anti-depressant use, family history
of Alzheimer’s disease, APOE e4 status and interval between visits, positive affect was associated with greater cerebral glu-
cose metabolism across para-/limbic, frontal, temporal and parietal regions. Our findings provide evidence that positive af-
fect in late midlife is associated with greater brain health in regions involved in affective processing and also known to be
susceptible to early neuropathological processes. The current findings may have implications for interventions aimed at
increasing positive affect to attenuate early neuropathological changes in at-risk individuals.
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Introduction
Positive affect refers to pleasant emotional and mood states,
broadly experienced as happiness, enthusiasm, contentment,
coping, well-being and optimism (Folkman and Moskowitz,
2000; Lyubomirsky et al., 2005; Pressman and Cohen, 2005). Over
the past few decades research has provided evidence of the as-
sociation between positive affect and beneficial outcomes
across many important psychosocial (Connolly and
Viswesvaran, 2000; Fredrickson et al., 2003; Kashdan and
Roberts, 2004; Lyubomirsky et al., 2005; Ruvolo, 1998; Wright and
Staw, 1999) and health domains (Boehm and Kubzansky, 2012;
Davidson et al., 2010; Ostir et al., 2001; Steptoe et al., 2005).
Furthermore, studies have demonstrated that positive affect
and related measures of happiness and well-being are associ-
ated with healthy aging and reduced mortality (Danner et al.,
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2001; Diener and Chan, 2011; Krijthe et al., 2011; Levy et al., 2002;
Moskowitz, 2003; Ostir et al., 2000; Steptoe et al., 2015; but see Liu
et al., 2016). While the direction of causality between positive af-
fect and beneficial outcomes, particularly within the domains of
health and longevity (Liu et al., 2016; Lyubomirsky et al., 2005),
requires further evaluation, it is reasonable to postulate that
positive affect may also be associated with brain health.
Cerebral glucose metabolism, indexed by positron emission
tomography (PET) tracer 18F-fluorodeoxyglucose (18F-FDG), is
an in vivo measure that is widely used as a marker of brain
health and function in normal aging and disease. In normal
aging, decreases in cerebral metabolism have been observed in
anterior brain regions (Kalpouzos et al., 2009; Pardo et al., 2007;
Petit-Taboue et al., 1998) with more pronounced disruption of
metabolic processes within temporoparietal regions in neurode-
generative diseases such as Alzheimer’s disease (AD) (Dukart
et al., 2013; Kalpouzos et al., 2009; Yoshizawa et al., 2014).
Abnormal cerebral glucose metabolism has also been consist-
ently observed within fronto-limbic regions in depression
(Drevets et al., 1997; Seminowicz et al., 2004), a disorder often
characterized by low levels of positive affect and high levels of
negative affect (Watson and Clark, 1997; Wichers et al., 2012).
Given the above evidence of age and disease-specific
changes in cerebral glucose metabolism as well as the beneficial
health outcomes associated with positive affect, it is possible
that levels of positive affect will also have an association with
cerebral glucose metabolism. To date, little is known about the
relationship between positive affect and brain health, particu-
larly in midlife when interventions aimed at modifying risk fac-
tors for pathological aging may be most effective. In the current
study, we examined the relationship between positive affect
and cerebral glucose metabolism in 133 healthy late middle-
aged adults who provided ratings of positive affect twice over a
two-year period and then underwent FDG-PET scanning. We
hypothesized that greater positive affect would be positively




This study used data from the Wisconsin Registry for
Alzheimer’s Prevention (WRAP) cohort (Table 1), a longitudinal
registry of> 1500 cognitively healthy adults recruited in middle-
age and enriched for AD risk factors of APOE e4 carriage and par-
ental family history of AD (Sager et al., 2005). Determination of
APOE e4 and FH status in this sample has been previously
described (Jonaitis et al., 2013; Koscik et al., 2014).
A total of 133 out of 178 asymptomatic late middle-aged
adults (mean age 59.29 years, SD¼ 6.11, range¼ 46.58–71.07,
71.4% female) were included in the current analyses if they had
completed a comprehensive neuropsychological battery, self-
report ratings of affect as indexed by the Center for
Epidemiologic Studies Depression Scale (CES-D), magnetic res-
onance imaging (MRI), FDG-PET; and were determined by neuro-
psychological evaluation and consensus review to be
cognitively normal, and absent of a major psychiatric diagnosis,
history of neurological disease and head trauma. Forty-five par-
ticipants were not included in the analyses for the following
reasons: 14 declined the FDG-PET scan, 11 were lost to follow-
up, nine had CES-D measurements that followed the FDG-PET
scan (see section labeled ‘Design’), four were MRI ineligible, four
had an abnormal FDG-PET scan and three were missing CES-D
data. The University of Wisconsin Institutional Review Board
approved all study procedures and each participant signed in-
formed consent prior to participation.
Design
Participants completed the CES-D on two different visits sched-
uled approximately two years apart (mean visit 1 to visit 2 inter-
val¼ 26.63 months, SD¼ 3.47) prior to the FDG-PET scan.
Participants then underwent FDG-PET scanning 20 months
after their second visit (mean visit 1 to FDG-PET scan inter-
val¼ 47.23 months; SD¼15.46 and mean visit 2 to FDG-PET scan
interval¼ 20.60 months; SD¼ 15.85).
Self-report measures
The CES-D, a well-validated questionnaire composed of 20-
items designed to measure frequency of depressive symptoms
experienced over the past week (Radloff, 1977) was used to as-
sess affect. Factor analytic research on the internal structure of
the CES-D typically yields a four-factor structure (Positive
Affect, Negative Affect, Somatic Symptoms and Interpersonal
Problems) (Shafer, 2006). This structure was tested and con-
firmed in the current study sample. The four statements com-
prising the positive affect subscale (‘I felt that I was just as good
as other people’; ‘I felt hopeful about the future’; ‘I was happy’; ‘I
enjoyed life’) have previously been shown to be associated with
beneficial health outcomes (Ostir 2000; Moskowitz, 2003) and
were used to assess positive affect in the current study. For
each item, participants were asked to use a four-point Likert
scale (e.g. rarely/none, some/little, occasionally/moderate,
most/all of the time; scored 0–3, respectively) to indicate how
often they experienced a particular statement. Scores ranged
from 0 to 12, with higher scores equating to a greater frequency
and/or level of positive affect. A mean positive affect score
based on their ratings at the two visits was calculated for each
participant as a measure of characteristic positive affect
(Dotson et al., 2009a,b). We included the remaining 16-items of
the CES-D (CES-D-16) to control for depressive symptoms
(Stansbury et al., 2006). Scores ranged from 0 to 48, with higher
scores equating to more depressive symptoms. For each
Table 1. Participant characteristics
Variable Participants (N¼ 133)
Age at initial CES-D 59.29 (6.11)
Age at FDG-PET scan 63.22 (5.99)
Female, % 71.4
Caucasian, % 97
Education (years) 16.97 (2.97)
Initial MMSE 29.47 (0.87)
FH positive, % 66.9
APOE 4 positive, % 40.6
Perceived health statusa 3.81 (0.71)
Anti-depressant use, % 30.8
CES-D totala 5.89 (4.95)
CES-D positive affecta 10.64 (1.61)
CES-D-16 depressive symptomsa 4.52 (4.01)
aCalculated as the mean across two visits.
CES-D,Center for the Epidemiologic Studies Depression; FDG-PET, fluorodeoxyglucose
positron emission tomography; FH,parental family history of Alzheimer’s disease;
APOE 4,Apolipoprotein Epsilon-4; MMSE,Mini-Mental Status Examination. Non-per-
centage values are sample means with standard deviations in parentheses.
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participant, scores collected at each of the two visits were used
to calculate mean depressive symptoms. To assess perceived
health status at each visit participants were asked, ‘How would
you rate your current health?’ on a five-point Likert scale rang-
ing from ‘Poor’ to ‘Excellent’, with higher scores equating to
greater perceived health. A mean score of perceived health sta-
tus over the two visits was calculated and included to control
for potential confounding effects of ill health on positive affect
(Liu et al., 2016).
FDG-PET imaging
Each participant underwent FDG-PET imaging using the
Alzheimer’s Disease NeuroImaging Initiative protocol (Jagust
et al., 2010) including five mCi FDG injection with a 30-min up-
take period followed by a 30 min acquisition. To reduce inter-
subject variability participants abstained from food, caffeine, to-
bacco and medication for a minimum of 4 h prior to scanning.
Post-processing involved frame-to-frame realignment and sum-
mation of the 30 min emission scans. Images were co-registered
to the T1-weighted image, spatially normalized to the ICBM 152
atlas and smoothed to 8 mm using SPM12 (www.fil.ion.ucl.ac.
uk/spm). Intensity normalization was achieved by calculating
the mean signal over the pons and cerebellar vermis (Jagust and
Landau, 2012; Knopman et al., 2013) producing scaled images for
each participant that were used in second level analyses.
MRI
T1-weighted images were acquired for the purpose of coregist-
eration of FDG-PET scans. Participants underwent scanning on
a General Electric 3.0 Tesla Discovery MR750 MRI system with
an eight-channel head coil (Excite HD Brain Coil, GE Healthcare).
T1-weighted images were acquired in the axial plane with a 3D
fast spoiled gradient-echo sequence using the following param-
eters: inversion time (TI)¼ 450 ms; repetition time (TR)¼ 8.1 ms;
echo time (TE)¼ 3.2 ms; flip angle¼ 12; acquisition ma-
trix¼ 256 mm 256 mm, field of view (FOV)¼ 256 mm; slice
thickness¼ 1.0 mm.
Family history and APOE 4 status
To verify the diagnosis of AD in the parent, parental medical re-
cords, autopsy reports or results of the dementia questionnaire
(Kawas et al., 1994) were obtained and reviewed by a multidis-
ciplinary diagnostic consensus conference (Jonaitis et al., 2013;
Koscik et al., 2014; Sager et al., 2005). Absence of FH of AD was
verified through detailed medical history surveys and phone
interview with the participants. Genotyping for APOE e4 status
was done previously in WRAP and described elsewhere
(Johnson et al., 2011).
Statistical analyses
Associations between positive affect and glucose metabolism
were assessed using multiple regression analyses conducted in
SPM12. The model included positive affect as the main continu-
ous predictor variable with FDG-PET as the dependent measure.
Age at visit 1, sex, depressive symptoms, anti-depressant use at
visit 1 and/or visit 2, perceived health status, family history of
AD, APOE e4 status, and interval between visit 1 CES-D and
scanning were treated as covariates (Table 1). No covariate ex-
ceeded a Pearson product correlation of 0.5. Voxel-wise analyses
were restricted to gray matter using an explicit mask made by
thresholding the International Consortium for Brain Mapping
Tissue Probabilistic Atlases gray matter map at 0.20. This was
done to minimize type 1 errors, ensuring that voxels with less
than a 20% likelihood of being gray matter were not included in
analyses. Statistical parametric maps were thresholded at
P 0.001 (uncorrected) with a cluster extent threshold of> 100
contiguous voxels. Resulting clusters were considered signifi-
cant if they surpassed a threshold of P¼ 0.05, cluster-level
Family Wise Error (FWE) correction.
Results
Table 1 provides information on the participant characteristics
and self-report measures. Whole brain voxel-wise analysis re-
vealed a significant main effect of positive affect on cerebral
glucose metabolism (P< 0.05 FWE cluster-corrected) in the bilat-
eral posterior cingulate gyrus/precuneus; left angular/supar-
marginal gyrus; left middle/inferior temporal gyrus and left
middle/frontal gyrus where greater positive affect was associ-
ated with higher cerebral glucose metabolism in these regions
(See Figure 1 and Table 2 for maxima and submaxima within
each cluster).
Discussion
The current study examined the novel association between
positive affect and cerebral glucose metabolism in a healthy
late middle-aged sample. Consistent with our hypothesis,
whole-brain voxel-wise analyses revealed a significant associ-
ation between positive affect and cerebral glucose metabolism,
such that greater positive affect was positively associated with
relatively greater cerebral glucose metabolism within para-/lim-
bic, frontal, temporal and parietal regions. Broadly, these re-
gions have been implicated in functional neuroimaging studies
of affective processing (Blood et al., 1999; Damasio et al., 2000;
Davidson and Irwin, 1999; Duerden et al., 2013; Hofer et al., 2007;
Maddock et al., 2003; Phillips et al., 2008) and show changes in
glucose metabolism in depression (Fitzgerald et al., 2008; Su
et al., 2014), a disorder often characterized by low levels of posi-
tive affect (Watson and Clark, 1997; Wichers et al., 2012). In add-
ition, regional grey matter volume in the precuneus,
parahippocampus, medial prefrontal cortex and insula correlate
with models of well-being (Kong et al., 2015; Lewis et al., 2014);
which are constructs related to positive affect and often found
to be associated with beneficial health outcomes (Boehm and
Kubzansky, 2012; Ryan and Deci, 2001).
The positive association between positive affect and glucose
metabolism across para-/limbic, frontal, temporal and parietal
regions may be informed by a constructionist perspective, in
which a variety of more ‘basic psychological operations’ from a
complex array of distributed brain networks (Lindquist et al.,
2012) are involved in the monitoring, processing and generation
of affect (Damasio et al., 2000; Davidson, 2004; Lindquist et al.,
2015). As part of the paralimbic cortex, the PCC/precuneus, para-
hippocampus and insula each play a role as integrative hubs for
a variety of functional processes (Buckner et al., 2009) and are
involved in affective processing (Blood et al., 1999; Damasio
et al., 2000; Davidson and Irwin, 1999; Duerden et al., 2013;
Maddock et al., 2003; Phillips et al., 2008). The PCC/precuneus is a
highly active metabolic region (Raichle et al., 2001) involved in
facilitating the integration of interoceptive and exteroceptive
stimuli across a spectrum of attention (Leech and Sharp, 2014).
The core underlying function of the parahippocampus is to bind
contextual features (e.g. emotional content of a situation or ex-
perience) and link these features to a larger network of relevant
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memories in the association cortex (Aminoff et al., 2013;
Eichenbaum et al., 2007). The insula is positioned amidst these
regions with specific connections to the parahippocampus,
where it is involved in integrating internal homeostatic, visceral
and sensory signals (Craig, 2009, 2010; Nagai et al., 2007; Suzuki,
2009). The frontal regions spanning the middle and superior
frontal gyrus, and anterior cingulate gyrus, have extensive con-
nections to the para-/limbic system and subcortical structures
(€Ongür and Price, 2000), and support range of cognitive func-
tions relevant to affective processing including integration of
sensory and visceral information, evaluation and attribution of
affective stimuli and decision-making and self-regulation
(Bechara et al., 2000; Ochsner and Gross, 2005; Phillips et al.,
2008). Lastly, the left angular/supramarginal gyri are also
involved in emotional processing (Hofer et al., 2007) and con-
sidered a heteromodal convergence zone supporting the inte-
gration and conceptualization of information from sensory,
language and memory subsystems (Binder and Desai, 2011;
Ciaramelli et al., 2008; Seghier, 2013). Taken together, we broadly
suggest, that affect emerges when integrated representations
(e.g. PCC/precuneus; angular/supramarginal gyrus; insula) of in-
ternal and external sensory stimuli based on contextual infor-
mation from memories (e.g. para-/hippocampal gyrus) are
deemed relevant and meaningful to the individual (e.g. pre-
frontal/frontal cortices). Of course, this is only a partial account
based on our findings, thus evidence of additional regions (e.g.
amygdala) and models of affective processing (e.g. lateraliza-
tion; localist) (Davidson and Irwin, 1999; Rohr et al., 2013) de-
serve consideration.
Within our late middle-aged sample, the association be-
tween positive affect and cerebral glucose metabolism was
observed in a number of brain regions that are known to exhibit
progressive reductions in metabolism in prodromal stages of
AD, including the PCC, precuneus, para-/hippocampus and tem-
poral/parietal (Buckner et al., 2005; Chetelat et al., 2003;
Minoshima et al., 1997; Mosconi, 2005; Mosconi et al., 2009;
Protas et al., 2013). Affective changes associated with depressive
symptoms may be an important predictor of cognitive decline
and dementia (da Silva et al., 2013; Ownby et al., 2006; Stepaniuk
et al., 2008), and have been shown to correspond to alterations
in brain volume and cerebral blood flow in vulnerable brain re-
gions of older adults (Dotson et al., 2009a,b; Ries et al., 2009).
Given that we controlled for depressive symptoms, the relation-
ship between positive affect and cerebral glucose metabolism,
notably in brain regions that support integrative functions
involved in affective processing, suggests positive affect may be
an important factor associated with brain health in late midlife,
when neuropathological processes are only beginning to
emerge and may still be modifiable (Jessen et al., 2014; Sperling
et al., 2011).
This may have implications for interventions aimed at
increasing and/or maintaining positive affect (Layous et al.,
2011; Proyer et al., 2014; Seligman et al., 2005; Sin and
Lyubomirsky, 2009). Specifically, the ‘broaden and build’ theory
posits that positive affect expands the scope of ‘thought-action
repertoires’ (e.g. exploration, creative problem solving, cognitive
flexibility, broadening of attention), leading to a building of re-
sources and beneficial outcomes (Fredrickson, 2001, 2013;
Fredrickson et al., 2008). Consistent with this theory, positive af-
fect is associated with reduced morbidity for a variety of known
risk factors (e.g. cardiovascular; chronic stress) for AD (Boehm
and Kubzansky, 2012; Pressman and Cohen, 2005; Steptoe et al.,
2005), enhanced cognitive functioning (Ashby et al., 1999;
Carpenter et al., 2013; Yang et al., 2013), and as our work sug-
gests, relatively higher levels of cerebral glucose metabolism in
regions vulnerable to early neuropathological changes. Thus,
Table 2. Brain regions that showed a significant main effect of positive affect on glucose metabolism using voxel-wise analyses
Cluster location Hemisphere k x y z Peak t P (FWE)
Posterior cingulate gyrus (23, 29, 31), precuneus (7) B 1832 6 60 16 4.76 0.001
Angular/supramarginal gyrus (39, 40), insula (13), transverse temporal gyrus (41) L 1320 38 54 30 4.63 0.003
Middle temporal gyrus (21, 22), para-hippocampal gyrus, hippocampal gyrus,
inferior temporal gyrus (20)
L 738 54 42 6 4.43 0.031
Middle frontal gyrus (10), superior frontal gyrus (10/11), anterior cingulate gyrus (32) L 652 30 50 0 4.38 0.044
X, Y, Z coordinates of the peak voxel of each cluster are presented in Montreal Neurological Institute (MNI) space. Corresponding Brodmann areas are in parentheses.
B¼Bilateral; L, Left; k, number of contiguous voxels in cluster.
Fig. 1. Statistical parametric maps were thresholded at an uncorrected voxelwise threshold of P<0.001 with a cluster extent threshold of >100 contiguous voxels.
Resulting clusters were considered significant if they surpassed cluster-level threshold of P<0.05 with a Family Wise Error correction for multiple comparisons. Sagittal
and coronal slices were derived from a normalized T1 anatomical image.
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interventions targeting positive affect could have potential in
mitigating pathological processes associated with cognitive and
functional decline through increasing flexible and adaptive re-
sponses (e.g. thought-action repertoires) to environmental de-
mands and/or optimizing cerebral glucose metabolism within
these particular brain regions. Of course, this is highly specula-
tive, and warrants examination with more sophisticated model-
ing techniques and measures to further clarify the causal
relationships between these variables.
There are potential limitations of our study that deserve
mentioning. First, because over half the participants in this
study have a family history of AD (66.9%), were late middle-
aged (m¼ 59.29 yrs-old), highly educated (m¼ 16.97 yrs) and pre-
dominantly Caucasian (97.0%), the generalizability of our results
is limited and would benefit from replication in more diverse
samples. Second, while we included a measure of perceived
health, which has been shown to attenuate the association be-
tween happiness and all-cause mortality (Liu et al., 2016), we did
not examine a variety of specific psychological (e.g. personality,
coping style), health (e.g. cardiovascular, endocrine, exercise)
and social factors (e.g. social stress and support, income) that
may be associated with positive affect (Lyubomirsky et al., 2005).
Lastly, we speculate based on the literature regarding possible
connectivity between regions, thus future analyses employing
connectivity methods for FDG-PET data would be useful.
In conclusion, this study provides initial evidence that posi-
tive affect is associated with cerebral glucose metabolism in
brain regions that support a variety of integrative functions
involved in affective processing. A number of these regions are
also known to be vulnerable to early progressive neurodegener-
ative changes, and therefore lay the foundation for future stud-
ies investigating the longitudinal relationship between positive
affect and factors associated with pathological aging and brain
health. Additionally, our findings highlight the potential for
interventions aimed at increasing and/or maintaining positive
affect, particularly in late-middle aged adults when early pre-
clinical neuropathological processes may still be modifiable.
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